Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Economics & Policy Update: Edwards, Abbott resolve patent dispute | Hypertension screening guidelines
Tuesday, July 14, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Economics

Top Stories

Edwards Lifesciences, Abbott agree to end patent dispute

In a statement announcing the news, Edwards said it “considers this agreement a positive development."

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Edwards Lifesciences, Abbott agree to end patent dispute

Share on Twitter Share on Facebook Share on Linkedin
In a statement announcing the news, Edwards said it “considers this agreement a positive development."
READ MORE >

Cardiology’s revenue down 57% in March, 73% in April

Cardiology has seen its revenue and utilization take significant hits as a result of the COVID-19 pandemic.

READ MORE >
COVID clinician
Share on Twitter Share on Facebook Share on Linkedin

Cardiology’s revenue down 57% in March, 73% in April

Share on Twitter Share on Facebook Share on Linkedin
COVID clinician
Cardiology has seen its revenue and utilization take significant hits as a result of the COVID-19 pandemic.
READ MORE >

COVID-19 could cost US hospitals $323B in 2020 alone

The report comes as confirmed cases continue to rise in certain parts of the country. If that surge continues, the pandemic's financial impact “could be even more significant.”

READ MORE >
Mask
Share on Twitter Share on Facebook Share on Linkedin

COVID-19 could cost US hospitals $323B in 2020 alone

Share on Twitter Share on Facebook Share on Linkedin
Mask
The report comes as confirmed cases continue to rise in certain parts of the country. If that surge continues, the pandemic's financial impact “could be even more significant.”
READ MORE >

Novo Nordisk acquires Corvidia Therapeutics for $2.1B with eye on cardiovascular disease

An antibody currently being developed by Corvidia, ziltivekimab, is at the center of the big acquisition.

READ MORE >
Researchers found millions of heart failure patients who qualify for standard, guideline directed medical therapies, but did not receive it due to poor health literacy, limited access to care and medication costs.
Share on Twitter Share on Facebook Share on Linkedin

Novo Nordisk acquires Corvidia Therapeutics for $2.1B with eye on cardiovascular disease

Share on Twitter Share on Facebook Share on Linkedin
Researchers found millions of heart failure patients who qualify for standard, guideline directed medical therapies, but did not receive it due to poor health literacy, limited access to care and medication costs.
An antibody currently being developed by Corvidia, ziltivekimab, is at the center of the big acquisition.
READ MORE >

USPSTF reaffirms recommendation for hypertension screening among adults

The U.S. Preventive Services Task Force has reaffirmed its recommendation that all adults undergo hypertension screening, calling it “a major contributing risk factor to heart failure, heart attack, stroke and chronic kidney disease.”

READ MORE >
Blood Pressure
Share on Twitter Share on Facebook Share on Linkedin

USPSTF reaffirms recommendation for hypertension screening among adults

Share on Twitter Share on Facebook Share on Linkedin
Blood Pressure
The U.S. Preventive Services Task Force has reaffirmed its recommendation that all adults undergo hypertension screening, calling it “a major contributing risk factor to heart failure, heart attack, stroke and chronic kidney disease.”
READ MORE >

Featured Articles

Tim Attebery, former American College of Cardiology and MedAxiom CEO, named Vxtra Health board chair

Back in April, Attebery announced his resignation from the ACC and MedAxiom.

READ MORE >
Timothy W. Attebery
Share on Twitter Share on Facebook Share on Linkedin

Tim Attebery, former American College of Cardiology and MedAxiom CEO, named Vxtra Health board chair

Share on Twitter Share on Facebook Share on Linkedin
Timothy W. Attebery
Back in April, Attebery announced his resignation from the ACC and MedAxiom.
READ MORE >

Diversity remains a big problem in cardiology—here’s how educators can help

Experts agree that cardiology programs can help address the specialty's diversity problem—but what steps can be taken to make a real difference?  

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Diversity remains a big problem in cardiology—here’s how educators can help

Share on Twitter Share on Facebook Share on Linkedin
Experts agree that cardiology programs can help address the specialty's diversity problem—but what steps can be taken to make a real difference?  
READ MORE >

Endologix announces bankruptcy, company-wide reorganization due to pandemic-related challenges

Endologix, an Irvine, California-based healthcare company focused on aortic disorders, has filed for Chapter 11 bankruptcy and finalized a “consensual plan of reorganization."

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Endologix announces bankruptcy, company-wide reorganization due to pandemic-related challenges

Share on Twitter Share on Facebook Share on Linkedin
Endologix, an Irvine, California-based healthcare company focused on aortic disorders, has filed for Chapter 11 bankruptcy and finalized a “consensual plan of reorganization."
READ MORE >

Heart valve specialists raise $20M

Foldax, a Salt Lake City-based healthcare company focused on heart valve technology, has closed a $20 million Series D round of financing.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Heart valve specialists raise $20M

Share on Twitter Share on Facebook Share on Linkedin
Foldax, a Salt Lake City-based healthcare company focused on heart valve technology, has closed a $20 million Series D round of financing.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme